164 related articles for article (PubMed ID: 36935920)
1. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
PeerJ; 2023; 11():e15025. PubMed ID: 36935920
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
3. [Risk factors of recurrence or metastasis in patients with medullary thyroid carcinoma].
Guo FL; Li LJ; Ruan XH; Fu GM; Zhao JZ; Hou XK; Gao M; Zheng XQ
Zhonghua Yi Xue Za Zhi; 2022 Dec; 102(48):3849-3855. PubMed ID: 36540922
[No Abstract] [Full Text] [Related]
4. Metastatic Lymph Node Ratio for Predicting Recurrence in Medullary Thyroid Cancer.
Kim J; Park J; Park H; Choi MS; Jang HW; Kim TH; Kim SW; Chung JH
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830996
[TBL] [Abstract][Full Text] [Related]
5. A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio.
Xu P; Wu D; Liu X
Endocrine; 2023 Jul; 81(1):107-115. PubMed ID: 36823341
[TBL] [Abstract][Full Text] [Related]
6. Lymph Node Ratio as a Predictive Factor of Persistent/Recurrent Disease in Patients With Medullary Thyroid Cancer: A Single-Center Retrospective Study.
Prinzi A; Frasca F; Russo M; Le Moli R; Belfiore A; Malandrino P
Endocr Pract; 2024 Mar; 30(3):194-199. PubMed ID: 38008257
[TBL] [Abstract][Full Text] [Related]
7. Ratio of positive lymph nodes: The prognostic value in stage IV thyroid cancer.
Jiang T; Huang C; Xu Y; Su Y; Zhang G; Xie L; Huang L; You S; Zha J
Oncotarget; 2017 Oct; 8(45):79462-79468. PubMed ID: 29108325
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of the Number of Harvested Lymph Nodes and Cut-Off for Lymph Node Ratio in the Prognosis of Stage II and III Colorectal Cancer Patients.
Li Destri G; Barchitta M; Pesce A; Latteri S; Bosco D; Di Cataldo A; Agodi A; Puleo S
J Invest Surg; 2019 Jan; 32(1):1-7. PubMed ID: 28972442
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Lymph Node Ratio in Patients with Resected Synchronous Colorectal Liver Metastases and Less Than 12 Examined Lymph Nodes.
Alexandrescu ST; Selaru FM; Diaconescu AS; Zlate CA; Blanita D; Grigorie RT; Zarnescu NO; Herlea V; Popescu I
J Gastrointest Surg; 2022 Jan; 26(1):141-149. PubMed ID: 34258674
[TBL] [Abstract][Full Text] [Related]
11. Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.
Back K; Kim TH; Lee J; Kim JS; Choe JH; Oh YL; Cho A; Kim JH
J Pediatr Surg; 2023 Mar; 58(3):568-573. PubMed ID: 35973863
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
Yang H; Mei T
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
[TBL] [Abstract][Full Text] [Related]
13. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
14. Lymph node ratio in lateral neck is an independent risk factor for recurrence-free survival in papillary thyroid cancer patients with positive lymph nodes.
Luo Z; Hei H; Qin J; Zheng C; Gong W
Endocrine; 2022 Dec; 78(3):484-490. PubMed ID: 36018538
[TBL] [Abstract][Full Text] [Related]
15. [Impact of regional positive lymph node ratio of gallbladder carcinoma on prognosis].
Zhou YM; Mi HC; Jiang W; Jiang Y; Hua YF; Lu CJ; Wang CN; Lu CD
Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1202-1207. PubMed ID: 36380669
[No Abstract] [Full Text] [Related]
16. Development of a simplified tumor-lymph node ratio classification system for patients with resected gastric cancer: A western study.
Díaz Del Arco C; Estrada Muñoz L; Sánchez Pernaute A; Ortega Medina L; García Gómez de Las Heras S; García Martínez R; Fernández Aceñero MJ
Ann Diagn Pathol; 2021 Feb; 50():151677. PubMed ID: 33310591
[TBL] [Abstract][Full Text] [Related]
17. Lymph node ratio is superior to AJCC N stage for predicting recurrence in papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Qadri Z; Ahmed SO; DeVera F; Al-Sobhi S; Al-Dayel F; Al-Kuraya KS
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35044932
[TBL] [Abstract][Full Text] [Related]
18. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
[TBL] [Abstract][Full Text] [Related]
19. Assessing the role of central lymph node ratio in predicting recurrence in N1a low-to-intermediate risk papillary thyroid carcinoma.
Ma T; Cui J; Shi P; Liang M; Song W; Zhang X; Wang L; Shi Y
Front Endocrinol (Lausanne); 2023; 14():1158826. PubMed ID: 37790606
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Impact of Lymph Node Ratio in Patients Undergoing Preoperative Chemoradiotherapy Followed by Curative Resection for Locally Advanced Rectal Cancer.
Jung W; Kim K; Kim J; Shim SJ
In Vivo; 2020; 34(3):1247-1253. PubMed ID: 32354915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
